These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
705 related items for PubMed ID: 10825149
21. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. Hu X, Cress WD, Zhong Q, Zuckerman KS. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):930-9. PubMed ID: 11027571 [Abstract] [Full Text] [Related]
22. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells. Wang QM, Feinman R, Kashanchi F, Houghton JM, Studzinski GP, Harrison LE. Clin Cancer Res; 2000 Jul 05; 6(7):2951-8. PubMed ID: 10914745 [Abstract] [Full Text] [Related]
23. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA, DeLorenzo RJ, Tombes RM. Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994 [Abstract] [Full Text] [Related]
24. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation. Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M. Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176 [Abstract] [Full Text] [Related]
25. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes. Parreño M, Garriga J, Limón A, Albrecht JH, Graña X. Oncogene; 2001 Aug 09; 20(35):4793-806. PubMed ID: 11521191 [Abstract] [Full Text] [Related]
26. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor. Khwaja F, Djakiew D. Mol Carcinog; 2003 Mar 09; 36(3):153-60. PubMed ID: 12619038 [Abstract] [Full Text] [Related]
27. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts. Kilbey A, Stephens V, Bartholomew C. Cell Growth Differ; 1999 Sep 09; 10(9):601-10. PubMed ID: 10511310 [Abstract] [Full Text] [Related]
29. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. Crit Rev Biochem Mol Biol; 1996 Jun 09; 31(3):237-71. PubMed ID: 8817077 [Abstract] [Full Text] [Related]
30. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Oncogene; 2001 Apr 19; 20(17):2055-67. PubMed ID: 11360190 [Abstract] [Full Text] [Related]
31. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195 [Abstract] [Full Text] [Related]
32. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes. Robles SJ, Shiyanov P, Aristodemo GT, Raychaudhuri P, Adami GR. DNA Cell Biol; 1998 Jan 15; 17(1):9-18. PubMed ID: 9468218 [Abstract] [Full Text] [Related]
38. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Afshari CA, Nichols MA, Xiong Y, Mudryj M. Cell Growth Differ; 1996 Aug 15; 7(8):979-88. PubMed ID: 8853893 [Abstract] [Full Text] [Related]
40. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. J Biol Chem; 1997 Aug 22; 272(34):20971-4. PubMed ID: 9261093 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]